#Dr garrison series#

He also oversaw the development and launch of the BD SoloShot Mini™, including its use in the meningitis vaccine program in sub-Saharan Africa, and the vaccination of the population under age 6 in Haiti. He actively led innovation for dozens of product lines, including the BD Emerald™ family of syringes, which enabled more than one billion safe injections in the first two years. Over the next decade, he built organizations as an R&D leader and general business manager.

#Dr garrison series#

In 2005, he joined BD, where he began a series of high-impact product development and deployment projects focusing on safety-engineered hypodermic needles and syringes for use in a range of settings around the world. While at Edwards, he helped develop and launch the Flo-Trac Cardiac Output Monitoring System™, now used to monitor more than 1.5 million patients. He then moved to Edwards Lifesciences to improve cardiovascular care by leading development of surgical heart valve products and developing less-invasive technologies to monitor critically ill patients. Within the first three years of earning his degree, he developed a number of significant technologies, including the first handheld computing glucose module with integrated mobile diabetes management software. He took a position with Roche Diagnostics, which led to a global marketing and business development role building on his technical expertise.

“He brings credit to our College and our University every day through his technical excellence, humanity, and strong sense of fairness and justice,” he wrote.įollowing graduation from UW, his career trajectory focused on making an impact. Ratner cited his exceptional leadership ability, excellence in research, vision, and his ability to solve complex problems by making creative connections. & Myrna Darland Endowed Chair in Technology Commercialization and Dr. Michael Garrison was a standout student, says Buddy Ratner, the Michael L.

Garrison came to the UW with a master’s in biomedical engineering from Duke University and having spent a few years in industry at Cygnus Therapeutic Systems, where he led the technology transfer of transformative technology to allow diabetes patients to non-invasively monitor glucose levels. As bioengineers, we often talk about translating technologies to the clinic to serve humanity.… Mike has done this over and over again in a relatively short career.”ĭr. studies at UW with his business instincts to focus on products that can change the human condition. Garrison for the Diamond Award, Matt O’Donnell, Frank & Julie Jungers Dean Emeritus and professor of bioengineering wrote, “What Mike has done that is very rare and worth recognition is to combine his deep technical knowledge developed during his Ph.D. Garrison has inspired and developed products impacting billions of patients. Now vice president of R&D at Becton Dickinson and Co. Garrison’s career has grown and evolved steadily, as he developed and launched medical products engineered to improve health care safety, disease management and infection prevention for providers and patients around the world. In the 16 years since earning his Ph.D., Dr. Online Master of Pharmaceutical Bioengineering (PharBE).